Making Glioblastoma a Target for Immunotherapy: A Road From Biomarker Discovery to Harnessing the Tumor Microenvironment

Time: 3:30 pm
day: Conference Day Two


  • Discussing the use of vaccines for the treatment of glioblastomas
  • Identifying circulating biomarkers, the past and the present
  • Addressing hurdles to overcome to implement the next steps